Characteristic T Helper 2 T Cell Cytokine Abnormalities in Autoimmune Lymphoproliferative Syndrome, a Syndrome Marked by Defective Apoptosis and Humoral Autoimmunity

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1912-1918

  Fuss, Ivan J ^a   Strober, Warren ^a,e   Dale, Janet K ^b   Fritz, Scott ^d   Pearlstein, Glen R ^a   Puck, Jennifer M ^c   Lenardo, Michael J ^a   Straus, Stephen E ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d SAIC FREDERICK INC   (United States)

^e LCI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 10; LYMPHOKINE;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIOSYNTHESIS; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; INFANT; LYMPHOPROLIFERATIVE DISEASE; MACROPHAGE; METABOLISM; MONOCYTE; PRESCHOOL CHILD; SECRETION; SYNDROME; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

ADOLESCENT; ADULT; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CYTOKINES; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INFANT; INTERLEUKIN-10; LYMPHOKINES; LYMPHOPROLIFERATIVE DISORDERS; MACROPHAGES; MONOCYTES; SYNDROME; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 0031568651     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sneller, M. C., S. E. Straus, E. S. Jaffe, J. S. Jaffe, T. A. Fleisher, M. Stetler-Stevenson, and W. Strober. 1992. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J. Clin. Invest. 90:334.
2. -) alpha beta T-cell receptor positive cells from an immunodeficient patient. Scand. J. Immunol. 34:635.
3. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
4. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. Roberts, K. M. Debatin, A. Fischer, and J. P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
5. Le Deist, F., E. Jean-Francois, F. Rieux-Laucat, M. Benkerrou, I. Roberts, N. Brousse, and A. Fischer. 1996. Clinical, immunological, and pathologic consequences of Fas-deficient conditions. Lancet 348:719.
6. Yokoyama, W. M. 1991. Monoclonal antibody supernatant and ascites fluid production. In Current Protocols In Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Greene Publishing and Wiley Interscience, New York, Chapter 2.6.4.
7. Kanof, M. E. 1991. Preparation of human mononuclear cell populations and subpopulations. In Current Protocols In Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Greene Publishing and Wiley Interscience, New York, Chapters 7.1 and 7.2.
8. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157:1261.
9. Holmes K., and B. J. Fowlkes. 1991. Preparation of cells and reagents for flow cytometry. In Current Protocols In Immunology, J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Greene Publishing and Wiley Interscience, New York, Chapters 5.3.1 and 7.4.1.
10. Wanidworanun, C., and W. Strober. 1993. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151:6853.
11. Eisenstein, E. M., K. Chua, and W. Strober. 1994. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10. J. Immunol. 152:5957.
12. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
13. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
14. Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, D. Bhat, W. Din, R. G. Goodwin, and M. F. Seldin. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131.
15. Nagata, S., and P. Goldstein. 1995. The Fas death factor. Science 267:1449.
16. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D. H. Sher, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 373:444.
17. Sneller, M. C., J. Wang, J. K. Dale, W. Strober, L. A. Middelton, Y. Choi, T. A. Fleisher, M. S. Lim, E. S. Jaffe, J. M. Puck, M. J. Lenardo, and S. E. Straus. 1996. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood. In press.
18. Davignon, J., P. L. Cohen, and R. A. Eisenberg. 1988. Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr/lpr mice. J. Immunol. 141:1848.
19. + double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR. J. Immunol. 151:597.
20. Mori, K., S. Kobayashi, M. Inobe, W. Y. Jia, M. Tamakoshi, T. Miyazaki, and T. Uede. 1994. In vivo cytokine gene expression in various T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Autoimmunity 17:49.
21. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008.
22. Ramsdell, F., M. S. Seaman, R. E. Miller, K. S. Picha, M. K. Kennedy, and D. H. Lynch. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1545.
23. Cush, J. J., J. B. Splawski, R. Thomas, J. E. McFarlin, H. Schulze-Koops, L. S. Davis, K. Fujita, and P. E. Lipsky. 1995. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38:96.
24. Llorente, L., Y. Richaud-Patin, R. Fior, J. Alcocer-Varela, J. Wijdenes, B. M. Fourrier, P. Galanaud, and D. Emilie. 1994. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 37:1647.
25. Hagiwara E., M. F. Gourley, S. Lee, and D. K. Klinman. 1996. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon gamma secreting cells in the peripheral blood. Arthritis Rheum. 39:379.
26. Llorente, L., W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdeness, J. Alcocer-Varela, B. Morel-Fourrier, J. C. Brouet, and I. Alacron-Segovia. 1995. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839.
27. 1 mice. J. Exp. Med. 179:305.
28. Ishida, H., R. Hastings, J. Kearney, and M. Howard. 1992. Continuous anti-interleukin-10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175:1213.
29. Prud'Homme, G. J., D. H. Kono, and A. N. Theofilopoulos. 1994. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β, interleukin-10 and interferon-γ mRNA in the lymph nodes of lupus-prone mice. Mol. Immunol. 32:495.
30. Levy, Y., and J. C. Brouet. 1994. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J. Clin. Invest. 93:424.
31. Moore, K., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
32. Schorlemmer, H. U., L. Lauffer, E. J. Kanzy, and K. Enssle. 1994. Immunoregulation by recombinant interleukin-4 receptor (IL-4-R) of murine GvH and SLE-like diseases in BDF1 hybrid mice and MRL/lpr autoimumme mice. Agents Action 41:C180.
33. Shirai, A., J. Conover, and D. M. Klinman. 1995. Increased activation and altered ratio of interferon-gamma:interleukin-4 secreting cells in MRL-lpr/lpr mice. Autoimmunity 21:107.